36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
18 °P sammeln
  • Broschiertes Buch

The purpose of this case study was to learn how US patent policy requirements differ for the Software and Pharmaceutical Industries, specifically if United States Patent Policy adequately protects intellectual property rights (IPR) for two divergent industries while still encouraging research and development (R & D) investment sufficient to increase profits and innovation. Data for this study consisted of 38 witness testimonies delivered to US Congress between the years 2005 and 2010 by experts representing the two industries of interest: pharmaceutical and software.

Produktbeschreibung
The purpose of this case study was to learn how US patent policy requirements differ for the Software and Pharmaceutical Industries, specifically if United States Patent Policy adequately protects intellectual property rights (IPR) for two divergent industries while still encouraging research and development (R & D) investment sufficient to increase profits and innovation. Data for this study consisted of 38 witness testimonies delivered to US Congress between the years 2005 and 2010 by experts representing the two industries of interest: pharmaceutical and software.
Autorenporträt
El Dr. Acheson tiene más de 25 años de experiencia en colaboración, creación de equipos y liderazgo. Sus intereses de investigación se centran en los avances de la innovación en una sociedad y los obstáculos a la innovación. Se centra en la política de patentes. El Dr. Acheson es actualmente miembro y revisor de manuscritos de la Healthcare Financial Management Association.